|
The full results of POCUS analysis for 29 OMIM diseases, over locus sizes of 100, 500 and 1,000 IDs at a threshold of 0.8 |
|||||||||||||||||
| Disease (representative OMIM number) |
Number of genes* |
Genes sharing† |
Correctly identified‡ |
Non-disease genes§ |
Total number of genes¶ |
Enrichment¥ |
|||||||||||
|
|
|
|
|
||||||||||||||
| 100 |
500 |
1,000 |
100 |
500 |
1,000 |
100 |
500 |
1,000 |
100 |
500 |
1,000 |
||||||
|
|
|||||||||||||||||
| Parkinson's disease (168600) |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
62 |
264 |
571 |
1 |
1 |
0 |
|||
| Lupus erythematosus, systematic (152700) |
3 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
43 |
262 |
547 |
0 |
1 |
1 |
|||
| Glaucoma, primary open angle, juvenile-onset (137750) |
3 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
59 |
279 |
527 |
1 |
1 |
1 |
|||
| Bardet Biedl (209900) |
4 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
75 |
390 |
776 |
0 |
1 |
1 |
|||
| Meningioma, familial (607174) |
4 |
2 |
1 |
0 |
0 |
6 |
17 |
10 |
69 |
363 |
722 |
2.46 |
0 |
0 |
|||
| Acute myelogenous leukemia, familial (601626) |
4 |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
84 |
385 |
771 |
1 |
1 |
1 |
|||
| Basal cell carcinoma (605462) |
4 |
3 |
2 |
0 |
0 |
0 |
0 |
0 |
83 |
418 |
810 |
20.8 |
1 |
1 |
|||
| Adrenoleukodystrophy, autosomal neonatal form (202370) |
4 |
4 |
2 |
0 |
0 |
0 |
3 |
3 |
76 |
369 |
733 |
19 |
0 |
0 |
|||
| Epidermolysis bullosa letalis (226700) |
4 |
4 |
3 |
2 |
2 |
2 |
1 |
4 |
73 |
380 |
728 |
11 |
63.3 |
60.67 |
|||
| Familial adenomatous polyposis (175100) |
4 |
4 |
3 |
2 |
0 |
8 |
12 |
4 |
64 |
371 |
727 |
4.36 |
13.3 |
0 |
|||
| Ovarian carcinoma (167000) |
4 |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
70 |
360 |
733 |
1 |
1 |
1 |
|||
| Hypertension (145500) |
5 |
2 |
0 |
0 |
0 |
3 |
0 |
0 |
95 |
472 |
920 |
0 |
1 |
1 |
|||
| Alzheimer's disease (104300) |
5 |
4 |
3 |
0 |
0 |
0 |
0 |
0 |
135 |
460 |
875 |
27 |
1 |
1 |
|||
| Charcot-Marie-Tooth disease, types 1A-1F (118200) |
5 |
4 |
3 |
0 |
0 |
0 |
0 |
0 |
98 |
449 |
937 |
19.6 |
1 |
1 |
|||
| Gastric cancer (137215) |
5 |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
87 |
483 |
932 |
1 |
1 |
1 |
|||
| Cystic fibrosis (219700) |
5 |
5 |
1 |
0 |
0 |
2 |
0 |
0 |
99 |
458 |
900 |
6.6 |
1 |
1 |
|||
| Inflammatory bowel disease (266600) |
5 |
5 |
2 |
0 |
2 |
3 |
0 |
3 |
99 |
506 |
1,013 |
7.92 |
1 |
81.04 |
|||
| Long-segment Hirschsprung disease (142623) |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
102 |
468 |
972 |
1 |
1 |
1 |
|||
| Leber congenital amaurosis (204000) |
6 |
5 |
5 |
0 |
0 |
4 |
0 |
0 |
125 |
508 |
1,120 |
11.6 |
1 |
1 |
|||
| Maturity onset diabetes of the young (606391) |
6 |
5 |
2 |
0 |
0 |
0 |
0 |
0 |
111 |
551 |
1,078 |
18.5 |
1 |
1 |
|||
| Prostate cancer (176807) |
6 |
5 |
0 |
0 |
0 |
2 |
0 |
0 |
128 |
550 |
1,157 |
0 |
1 |
1 |
|||
| Colorectal cancer, hereditary nonpolyposis (114500) |
6 |
6 |
5 |
6 |
6 |
4 |
14 |
17 |
115 |
560 |
1,095 |
10.6 |
28 |
47.61 |
|||
| Epiphyseal dysplasia, multiple types 1-5 (132400) |
7 |
6 |
6 |
3 |
0 |
4 |
0 |
0 |
135 |
596 |
1,232 |
11.6 |
85.1 |
1 |
|||
| Muscular dystrophy, limb-girdle, autosomal recessive (601173) |
7 |
5 |
2 |
0 |
0 |
1 |
0 |
0 |
124 |
634 |
1,282 |
11.8 |
1 |
1 |
|||
| Diabetes mellitus, non-insulin dependent (125853) |
8 |
6 |
2 |
0 |
0 |
0 |
0 |
0 |
155 |
719 |
1,420 |
19.4 |
1 |
1 |
|||
| Breast cancer (114480) |
9 |
7 |
3 |
0 |
0 |
2 |
0 |
0 |
170 |
819 |
1,592 |
11.3 |
1 |
1 |
|||
| Retinitis pigmentosa (268000) |
10 |
8 |
6 |
0 |
0 |
3 |
7 |
6 |
197 |
977 |
1,897 |
13.1 |
0 |
0 |
|||
| Cardiomyopathy, familial hypertrophic (192600) |
11 |
11 |
9 |
7 |
4 |
7 |
7 |
15 |
194 |
1,011 |
2,029 |
9.92 |
46 |
38.83 |
|||
| Thyroid carcinoma, papillary (188550) |
11 |
11 |
0 |
0 |
0 |
1 |
0 |
0 |
217 |
1,059 |
2,142 |
0 |
1 |
1 |
|||
|
* The total number of genes for a disease. †The number of disease genes that share IDs. ‡The number of disease genes above the threshold at the three locus sizes. §The number of non-disease genes above the threshold at the three locus sizes. ¶The total number of genes present at the loci considered. ¥The enrichment of disease genes in genes above the threshold compared with the initial loci, zeros denote diseases where only non-disease genes were above the theshold. | |||||||||||||||||
Turner et al. Genome Biology 2003 4:R75 doi:10.1186/gb-2003-4-11-r75 |
|||||||||||||||||